Degenerative changes in myometrium simulating diffuse leiomyomatosis after treatment with gonadotrophin releasing hormone analogue.
Degenerative changes are encountered relatively frequently in uterine leiomyomas. Morphologic changes within leiomyomas, particularly necrosis and alterations in cellularity, have been described following treatment with gonadotrophin releasing hormone analogue, but the effects of this form of treatment on the morphology of the normal myometrium are less well documented. A case is reported of a 42 year old woman with a history of menorrhagia in whom a combination of degenerative and iatrogenic changes resulted in a histological appearance resembling diffuse leiomyomatosis.
Jeffers
M
M
Department of Pathology, Royal Infirmary, Glasgow.
Cowan
C
C
Lunan
C B
CB
D000328:Adult; D005260:Female; D017273:Goserelin / Q000009:adverse effects*; D006801:Humans; D018231:Leiomyomatosis / Q000139:chemically induced* / Q000473:pathology; D009215:Myometrium / Q000187:drug effects* / Q000473:pathology; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000473:pathology
D017273:Goserelin